Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Raw Materials (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Raw Materials for 10 consecutive years, with $2.6 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 27.44% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.6 million through Dec 2025, up 27.44% year-over-year, with the annual reading at $2.6 million for FY2025, 27.44% up from the prior year.
  • Raw Materials hit $2.6 million in Q4 2025 for STRATA Skin Sciences, down from $2.9 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $5.8 million in Q3 2023 to a low of $2.0 million in Q4 2024.
  • Historically, Raw Materials has averaged $3.4 million across 5 years, with a median of $2.9 million in 2022.
  • Biggest five-year swings in Raw Materials: surged 79.43% in 2022 and later tumbled 58.53% in 2024.
  • Year by year, Raw Materials stood at $3.2 million in 2021, then decreased by 7.34% to $3.0 million in 2022, then fell by 26.1% to $2.2 million in 2023, then decreased by 6.89% to $2.0 million in 2024, then grew by 27.44% to $2.6 million in 2025.
  • Business Quant data shows Raw Materials for SSKN at $2.6 million in Q4 2025, $2.9 million in Q3 2025, and $3.2 million in Q2 2025.